Page 1 of 212

COPD overlooked in cardiovascular patients By Laura Cowen.

These symptoms, which can also include fatigue, tingling and numbness, are known as functional or psychogenic symptoms also. ‘People who have these symptoms make up one-third of all clinic visits, however the outcomes are poor,’ said study author Michael Sharpe, MD, of the University of Edinburgh in Scotland. Previous studies have shown that extreme cognitive behavioral therapy can decrease the symptoms, disability and distress in people who have these symptoms, but there are obstacles to providing this therapy. Continue reading

Aspirin desensitization procedure may benefit sufferers with sinusitis.

The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more serious, turning into bronchitis and asthma eventually, diminishing her ability to breathe and sapping her of her energy. The only complete relief came from aspirin; and the aspirin desensitization that allowed her to overcome her aspirin allergy and end her decades-long battle with sinusitis. John R. Cohn, MD, mind of the Adult Allergy Section at Thomas Jefferson University Medical center and professor of Medicine at Jefferson Medical University of Thomas Jefferson University can be among few allergists to perform the desensitization treatment which trains your body to tolerate aspirin, enhancing some patients with the triad of sinusitis, asthma, and aspirin-exacerbated respiratory disease , while allowing others to receive the complete great things about aspirin for cardiovascular and related disorders. Continue reading

Chiltern earns Gold Membership in CDISC Chiltern International Small.

Chiltern earns Gold Membership in CDISC Chiltern International Small , a worldwide contract research organization offers earned a Gold Membership in CDISC, the Clinical Data Interchange Specifications Consortium . CDISC can be a worldwide nonprofit organization which has established standards to aid the acquisition, exchange, submission, and archive of clinical research data. CDISC is comprised of almost 200 global agencies including leading Biotech and Pharmaceutical companies, CROs, and academic establishments. Their objective is to develop and support global data criteria that enable information exchange to boost medical study with a eyesight toward affected individual care and safety. Continue reading

Ban smoking in vehicles?

Ban smoking in vehicles? British doctors say yes Smoking bans are actually in place in every sorts of areas, including restaurants, bars, and parks in addition to workplaces . Right now the group that represents doctors in Britain is certainly calling on the federal government to snuff out cigarette smoking in cars – a stage that could exceed regulations elsewhere. Images: America’s smokiest metropolitan areas In analysis released on Wednesday, the British Medical Association stated that the confined environment in automobiles exposes motorists and passengers to 23 times more toxins when compared to a smoky bar. Continue reading

FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia FibroGen.

, announced today the initiation of the initial clinical research in the Phase 3 clinical development system of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia connected with chronic kidney disease in patients not on dialysis and on dialysis, to aid authorization in the U.S. And Europe. FG-4592/ASP1517 is an inhibitor of hypoxia-inducible factor prolyl hydroxylase , owned by a new class of anemia therapeutic brokers. The decision to initiate the Phase 3 plan in the U.S. Results relating to Phase 2 clinical advancement of FG-4592/ASP1517 were lately offered at the American Society of Nephrology Kidney Week 2012, in San Diego, California. Related StoriesRogosin selected to participate in new Comprehensive End-Stage Renal Disease Care ModelAdvances in nanofilter technology may lead to surgically implantable, artificial kidneyPatients with kidney failure at increased risk of developing different types of cancer Based on the encouraging results from FG-4592/ASP1517 Phase 2 scientific studies, we are pleased to advance to Stage 3 development of FG-4592/ASP1517, said Thomas B. Continue reading

Anthem proposes double-digit rate hikes in Calif.

Anthem proposes double-digit rate hikes in Calif. Marketplace: Are Insurers Hiking Rates Despite HEALTHCARE Reform California's insurance commissioner, Dave Jones, is upset regarding the latest rate hikes for health insurance diflucan intake . And he's using really the only power he's got: Stepping up to a podium and scolding the insurance companies. Specifically, he has known as out Anthem Blue Cross of California for an 11 % premium increase for a few customers. But Anthem's double-digit rate hike is consistent with new 2013 rates being rolled out all over the national country. Not exactly what the architects of healthcare reform had at heart. Continue reading

An epidemic of rest apnea Why didnt I find out about sleep apnea in medical school?

11. Take 5-HTP Researchers suggest serotonin precursors such as 5-HTP for people suffering from sleep apnea. Decreased serotonin levels can lead to sleep apnea. The nerves that control inhaling and exhaling require an adequate supply of serotonin. Incidentally, serotonin production depends upon magnesium. The suggested dosage is definitely 100 to 300 mg of 5-HTP at bedtime. 12. Join Future Health Now!. It’s my two-year Online Wellness Program. Remaining healthy is the best defense against all of the lifestyle diseases.About the writer:About the writer: Carolyn Dean MD ND may be the Doctor of the Future�. Continue reading

Response to antipsychotic medications.

Brain scans can help predict sufferers’ response to antipsychotic medications Investigators in The Feinstein Institute for Medical Analysis can see that brain scans may be used to predict sufferers' response to antipsychotic medications how-stress-affects-erectile-function.html . The results are published on-line in the latest problem of The American Journal of Psychiatry. Psychotic disorders, such as for example schizophrenia and bipolar disorder, are seen as a delusions, hallucinations, and disorganized behavior and thoughts. They are estimated that occurs in up to three % of the populace and are a respected cause for disability world-wide. Continue reading

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa.

Cipher strengthens Canadian dermatology portfolio with acquisition of Vaniqa, Actikerall Cipher Pharmaceuticals Inc. A., a Spanish pharmaceutical company. Both products have been approved by Wellness Canada. VANIQA is a prescription cream clinically proven to reduce the growth of undesired facial hair in ladies. VANIQA cream can be an enzyme inhibitor and works by blocking an enzyme necessary for hair to grow. The product was approved by Health Canada in-may, 2001. Actikerall is certainly indicated for the localized treatment of palpable and/or moderately heavy hyperkeratotic actinic keratosis slightly, a pre-cancerous patch of solid, scaly, or crusty epidermis. Actikerall has been shown to be more advanced than placebo and non inferior to diclofenac gel in the treatment of actinic keratosis. Continue reading

AVEO enter development.

Astellas, AVEO enter development, commercialization agreement for tivozanib Astellas Pharma Inc. , a worldwide pharmaceutical firm, and AVEO Pharmaceuticals, Inc. today announced they have entered into a worldwide contract outside of Asia to develop and commercialize tivozanib, AVEO’s lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad selection of cancers sildenafil reviews . AVEO can be eligible to receive approximately $1. At the mercy of regulatory acceptance, AVEO will business lead commercialization of tivozanib in THE UNITED STATES and Astellas will business lead commercialization of tivozanib in the European Union . Continue reading

Page 1 of 212